Hoth Therapeutics, Inc.
General ticker "HOTH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $15.5M (TTM average)
Hoth Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -5.2%.
Estimated limits based on current volatility of 5.5%: low 0.80$, high 0.89$
Factors to consider:
- Total employees count: 6 (0.0%) as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Insufficient capital, Clinical trial failure, Regulatory and compliance, Market competition, Acquisition/divestiture risks
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.68$, 2.03$]
- 2026-12-31 to 2027-12-31 estimated range: [0.61$, 1.85$]
Financial Metrics affecting the HOTH estimates:
- Positive: with PPE of -1.2 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Shareholder equity ratio, % of 80.89 > 64.23
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: -4.39 < Investing cash flow per share per price, % of -2.09
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term HOTH quotes
Long-term HOTH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $7.69MM | $8.22MM | $12.36MM |
| Operating Income | $-7.69MM | $-8.22MM | $-12.36MM |
| Non-Operating Income | $-0.15MM | $0.03MM | $-0.11MM |
| R&D Expense | $3.48MM | $3.25MM | $5.95MM |
| Income(Loss) | $-7.85MM | $-8.19MM | $-12.47MM |
| Net Income(Loss)* | $-7.85MM | $-8.19MM | $-12.47MM |
| Stockholders Equity | $8.82MM | $6.88MM | $6.15MM |
| Assets | $9.52MM | $7.71MM | $7.60MM |
| Operating Cash Flow | $-8.45MM | $-6.98MM | $-9.80MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.01MM | $0.02MM | $-0.30MM |
| Financing Cash Flow | $11.32MM | $4.74MM | $9.31MM |
| Earnings Per Share** | $-2.30 | $-1.28 | $-0.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.